Login

AUXILIUM PHARMACEUTICALS INC SEC Filings

Filed On Filing
25 May 2016 CT ORDER
16 Feb 2016 SC 13G/A
05 Mar 2015 AMENDMENT NO. 2 TO SCHEDULE TO-I
18 Feb 2015 SC 13G/A
17 Feb 2015 AQR CAPITAL MANAGEMENT LLC
17 Feb 2015 SC 13G/A
13 Feb 2015 AMENDMENT 5 AUXILIUM PHARMACEUTICALS, INC.
10 Feb 2015 PENTWATER CAPITAL MANAGEMENT LP. SC 13G 12-31-2014(AUXILIUM PHARMACEUTICALS INC.
10 Feb 2015 SC 13G/A
09 Feb 2015 15-12G
04 Feb 2015 SC 13G/A
04 Feb 2015 AMENDMENT NO. 1 TO SCHEDULE TO-I
03 Feb 2015 SC-TO-I
02 Feb 2015 Form 4: Flynn James E, 10% owner and 4 others

Disposed of 6,267,382 shares (Tender Offer)

30 Jan 2015 SC 13G/A
30 Jan 2015 Form 4: Wills Alan, EVP, Corporate Development

Disposed of 30,743 shares (Other Transaction) ($1.12M) · Disposed of 101,625 Nonqualified Employee Stock Option (Right to Buy) (Other Transaction) ($3.71M)

30 Jan 2015 Form 4: Tursi James Patrick, Chief Medical Officer

Disposed of 32,634 shares (Other Transaction) · Disposed of 128,688 Nonqualified Employee Stock Option (Right to Buy) (Other Transaction) ($4.7M) · Disposed of 12,500 Nonqualified Employe Stock Option (Right to Buy) (Other Transaction) ($457K)

30 Jan 2015 Form 4: Saik Andrew, CFO

Disposed of 10,000 shares (Other Transaction) ($365K) · Disposed of 165,000 Nonqualified Employee Stock Option (Right to Buy) (Other Transaction) ($6.03M)

30 Jan 2015 Form 4: Koven Andrew I, EVP, CAO, GC and Secretary

Disposed of 38,721 shares (Other Transaction) ($1.41M) · Disposed of 193,725 Nonqualified Employee Stock Option (Right to Buy) (Other Transaction) ($7.08M)

30 Jan 2015 Form 4: Jobes Elizabeth Varki, Chief Compliance Officer

Disposed of 13,767 shares (Other Transaction) ($503K) · Disposed of 44,950 Nonqualified Employee Stock Option (Right to Buy) (Other Transaction) ($1.64M)

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support